<DOC>
	<DOCNO>NCT00035269</DOCNO>
	<brief_summary>This study treat patient community-acquired pneumonia due specific bacteria ( S. pneumoniae )</brief_summary>
	<brief_title>New Antibiotic Treat Patients With Community-acquired Pneumonia Due Specific Bacteria ( S. Pneumoniae Pneumonia )</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Gram-Positive Bacterial Infections</mesh_term>
	<mesh_term>Community-Acquired Infections</mesh_term>
	<mesh_term>Pneumonia , Pneumococcal</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<criteria>Other specific inclusion/exclusion criterion may apply . In order determine eligibility , examination investigator necessary . Patients must sign symptoms pneumonia , chest xray showing pneumonia . The patient must S. pneumoniae ( specific bacteria ) grow sputum blood continue treatment . Patients take one day another antibiotic entering study . Patients HIV low CD4 count exclude .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Pharmacia</keyword>
</DOC>